These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19950262)

  • 1. Mediators of structural remodeling in peripheral spondylarthritis.
    Vandooren B; Yeremenko N; Noordenbos T; Bras J; Tak PP; Baeten D
    Arthritis Rheum; 2009 Dec; 60(12):3534-45. PubMed ID: 19950262
    [No Abstract]   [Full Text] [Related]  

  • 2. The abundant synovial expression of the RANK/RANKL/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation.
    Vandooren B; Cantaert T; Noordenbos T; Tak PP; Baeten D
    Arthritis Rheum; 2008 Mar; 58(3):718-29. PubMed ID: 18311801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the rank of RANKL in spondylarthritis?
    Loddenkemper K; Burmester GR
    Arthritis Rheum; 2008 Mar; 58(3):641-4. PubMed ID: 18311809
    [No Abstract]   [Full Text] [Related]  

  • 4. Quantification of cells expressing mesenchymal stem cell markers in healthy and osteoarthritic synovial membranes.
    Hermida-Gómez T; Fuentes-Boquete I; Gimeno-Longas MJ; Muiños-López E; Díaz-Prado S; de Toro FJ; Blanco FJ
    J Rheumatol; 2011 Feb; 38(2):339-49. PubMed ID: 21078714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced expression and proteolytic susceptibility of lubricin/superficial zone protein may explain early elevation in the coefficient of friction in the joints of rats with antigen-induced arthritis.
    Elsaid KA; Jay GD; Chichester CO
    Arthritis Rheum; 2007 Jan; 56(1):108-16. PubMed ID: 17195213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis.
    Vandooren B; Noordenbos T; Ambarus C; Krausz S; Cantaert T; Yeremenko N; Boumans M; Lutter R; Tak PP; Baeten D
    Arthritis Rheum; 2009 Apr; 60(4):966-75. PubMed ID: 19333931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone and joint destruction in rheumatoid arthritis: what is really happening?
    Goldring SR
    J Rheumatol Suppl; 2002 Sep; 65():44-8. PubMed ID: 12236623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone morphogenetic proteins in the development and healing of synovial joints.
    Edwards CJ; Francis-West PH
    Semin Arthritis Rheum; 2001 Aug; 31(1):33-42. PubMed ID: 11503137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of mesenchymal cells in the pathophysiology of inflammatory arthritis.
    Meyer LH; Franssen L; Pap T
    Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):969-81. PubMed ID: 16980218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional profiles discriminate bone marrow-derived and synovium-derived mesenchymal stem cells.
    Djouad F; Bony C; Häupl T; Uzé G; Lahlou N; Louis-Plence P; Apparailly F; Canovas F; Rème T; Sany J; Jorgensen C; Noël D
    Arthritis Res Ther; 2005; 7(6):R1304-15. PubMed ID: 16277684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skeletal stem/osteoprogenitor cells: current concepts, alternate hypotheses, and relationship to the bone remodeling compartment.
    Mödder UI; Khosla S
    J Cell Biochem; 2008 Feb; 103(2):393-400. PubMed ID: 17541947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High CCL18/PARC expression in articular cartilage and synovial tissue of patients with rheumatoid arthritis.
    Momohara S; Okamoto H; Iwamoto T; Mizumura T; Ikari K; Kawaguchi Y; Takeuchi M; Kamatani N; Tomatsu T
    J Rheumatol; 2007 Feb; 34(2):266-71. PubMed ID: 17304652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of the synovial T cell repertoire in anti-citrullinated protein antibody-positive rheumatoid arthritis.
    Cantaert T; Brouard S; Thurlings RM; Pallier A; Salinas GF; Braud C; Klarenbeek PL; de Vries N; Zhang Y; Soulillou JP; Tak PP; Baeten D
    Arthritis Rheum; 2009 Jul; 60(7):1944-56. PubMed ID: 19565497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mucopolysaccharide distribution in the synovial membrane of the joint and in the articular cartilages in rheumatoid arthritis--histochemical and ultrastructural observations].
    Watanabe Y; Otaka Y
    Ryumachi; 1975 Dec; 15(4):352-4. PubMed ID: 131376
    [No Abstract]   [Full Text] [Related]  

  • 15. Bone morphogenetic protein signaling in joint homeostasis and disease.
    Lories RJ; Luyten FP
    Cytokine Growth Factor Rev; 2005 Jun; 16(3):287-98. PubMed ID: 15993360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Repair of bone and articular destruction in rheumatoid arthritis].
    Kanbe K
    Clin Calcium; 2007 Apr; 17(4):541-5. PubMed ID: 17404483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical markers of joint damage: is there any hope?
    Wollheim FA
    Clin Exp Rheumatol; 1995; 13 Suppl 12():S3-5. PubMed ID: 8846542
    [No Abstract]   [Full Text] [Related]  

  • 18. Abundant expression of common cytokine receptor gamma chain (CD132) in rheumatoid joints.
    Nishio J; Kohsaka H; Shimamura T; Hamuro J; Miyasaka N
    J Rheumatol; 2001 Feb; 28(2):240-4. PubMed ID: 11246656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abundant expression of common cytokine receptor chain (CD132) in rheumatoid joints.
    Smith MD
    J Rheumatol; 2001 Nov; 28(11):2561-3. PubMed ID: 11708439
    [No Abstract]   [Full Text] [Related]  

  • 20. Multipotent mesenchymal stromal cells in articular diseases.
    Jorgensen C; Djouad F; Bouffi C; Mrugala D; Noël D
    Best Pract Res Clin Rheumatol; 2008 Apr; 22(2):269-84. PubMed ID: 18455684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.